A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Phase 1a is a dose escalation to evaluate the safety and tolerability of NX-2127 in adult patients with relapsed/refractory (R/R) […]
Diffuse Large B Cell Lymphoma (DLBCL)
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
Phase 1a is a dose escalation to evaluate the safety and tolerability of NX-5948 in adult patients with relapsed/refractory (R/R)
A Study of NX-1607 in Adults With Advanced Malignancies
Phase 1a will consist of 2 study arms: Monotherapy and Paclitaxel combo. Phase 1a dose escalation will evaluate the safety